Loading...
•
Dec 31, 2022
Stryker Q4 2022 Earnings Report
Stryker reported a net sales increase of 10.7% and an organic net sales increase of 13.2% for the fourth quarter of 2022.
Key Takeaways
Stryker reported strong fourth-quarter results with a 10.7% increase in net sales, reaching $5.2 billion, and a 13.2% increase in organic net sales. Adjusted EPS increased by 10.7% to $3.00. The company anticipates continued sales momentum in 2023.
Net sales increased by 10.7% to $5.2 billion.
Organic net sales increased by 13.2%.
Reported EPS decreased 15.0% to $1.47.
Adjusted EPS increased 10.7% to $3.00.
Stryker
Stryker
Forward Guidance
Stryker expects 2023 organic net sales growth to be in the range of 7.0% to 8.5% and adjusted net earnings per diluted share to be in the range of $9.85 to $10.15.
Positive Outlook
- Expects 2023 organic net sales growth to be in the range of 7.0% to 8.5%.
- Adjusted net earnings per diluted share to be in the range of $9.85 to $10.15.
- Based on the steady progress of pricing actions, the impact of price to be between 0% and -0.5%.
- Good momentum in many parts of business heading into 2023.
- Alleviating supply chain disruptions.
Challenges Ahead
- Macro-economic volatility.
- Inflationary risks.
- Currency fluctuations.
- Sales will be modestly unfavorably impacted as compared to 2022 if foreign exchange rates hold near their current levels.
- EPS will be modestly unfavorably impacted as compared to 2022 if foreign exchange rates hold near their current levels.